Ikonisys SA - Asset Resilience Ratio
Ikonisys SA (ALIKO) has an Asset Resilience Ratio of 0.13% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ALIKO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2022)
This chart shows how Ikonisys SA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Ikonisys SA.
Liquid Assets Composition Over Time
This chart breaks down Ikonisys SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Ikonisys SA total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €27.40K | 0.13% |
| Total Liquid Assets | €27.40K | 0.13% |
Asset Resilience Insights
- Limited Liquidity: Ikonisys SA maintains only 0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ikonisys SA Industry Peers by Asset Resilience Ratio
Compare Ikonisys SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for Ikonisys SA (2021–2022)
The table below shows the annual Asset Resilience Ratio data for Ikonisys SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.16% | €35.76K ≈ $41.81K |
€21.72 Million ≈ $25.39 Million |
-0.04pp |
| 2021-12-31 | 0.21% | €46.76K ≈ $54.67K |
€22.52 Million ≈ $26.33 Million |
-- |
About Ikonisys SA
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the flu… Read more